Zheng Xiao

Zheng Xiao

Auto-generated profile, based on publicly available information

Zheng Xiao

Department of Neurology, The First Affiliated Hospital of Chongqing Medical University, Chongqing, China

Research Focus & Metrics

Academic Career Length

19Years (2008-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
8 June 2018 in Frontiers in Immunology
Verified
Journal Article
Open access
PDF file
YGYi Guo
Yi Guo
XTXin Tian
Xin Tian
XWXuefeng Wang
Xuefeng Wang
ZXZheng Xiao
Zheng Xiao
Immunoglobulin has been widely used in a variety of diseases, including primary and secondary immunodeficiency diseases, neuromuscular diseases, and Kawasaki disease. Although a large number of clinical trials have demonstrated that immunoglobulin is effective and well tolerated, various adverse effects have been reported. The majority of these events, such as flushing, headache, malaise, fever, chills, fatigue and lethargy, are transient and mild. However, some rare side effects, including renal impairment, thrombosis, arrhythmia, aseptic meningitis, hemolytic anemia, and transfusion-related acute lung injury (TRALI), are serious. These adverse effects are associated with specific immunoglobulin preparations and individual differences. Performing an early assessment of risk factors, infusing at a slow rate, premedicating, and switching from intravenous immunoglobulin (IVIG) to subcutaneous immunoglobulin (SCIG) can minimize these adverse effects. Adverse effects are rarely disabling or fatal, treatment mainly involves supportive measures, and the majority of affected patients have a good prognosis.

12 November 2019 in Frontiers in Immunology
Verified
Journal Article
Open access
PDF file
YGYixue Gu
Yixue Gu
MZMin Zhong
Min Zhong
LHLiang He
Liang He
WLWei Li
Wei Li
YHYuanyuan Huang
Yuanyuan Huang
ZXZheng Xiao
Zheng Xiao
In recent years, as an increasing number of neuronal autoantibodies have been detected and used for clinical diagnosis, clinicians have become more aware of autoimmune encephalitis, causing its reported incidence to trend upward over several years. To date, however, there has been no large-scale epidemiological survey of autoimmune encephalitis in adults and children, and its epidemiological characteristics remain unclear. Six main types of antibodies are detected and used to diagnose autoimmune encephalitis in Chongqing, Southwestern China: anti-NMDA receptor antibody, anti-GABAB receptor antibody, anti-LGI1 antibody, anti-CASPR2 antibody, anti-AMPA1 receptor antibody, and anti-AMPA2 receptor antibody. From January 2012 to February 2018, 189 patients at six general hospitals in Chongqing were diagnosed with autoimmune encephalitis and were positive for neuronal autoantibodies. In this report, the epidemic situation and the antibody distribution among these patients are analyzed and described in detail. The differences in disease severity among different ages and between the sexes are evaluated, and the correlation between antibody titer and disease severity is also assessed.

9 January 2016 in Neurological Sciences
Verified
Journal Article
Closed access
PDF file
WCWei Chunling
Wei Chunling
XZXiao Zheng
Xiao Zheng

1 October 2021 in Seizure: European Journal of Epilepsy
Verified
Journal Article
Closed access
YZYuping Zhao
Yuping Zhao
XLXing Liu
Xing Liu
ZXZheng Xiao
Zheng Xiao

1 June 2018 in Genes & Diseases
Verified
Journal Article
Open access
JLJin Liao
Jin Liao
XTXin Tian
Xin Tian
HWHao Wang
Hao Wang
ZXZheng Xiao
Zheng Xiao
Epilepsy and migraine often co-occur. From the clinical symptoms, they often have some signs of symptoms before onset; from the pathogenesis of epilepsy and migraine, both of them have a high degree of neuronal excitement and ion channel abnormalities; in terms of treatment, many antiepileptic drugs are work in migraine. All of this indicates that they interact with each other. But it is undeniable that there are interactions and relationships between them, and there are also some differences such as the different clinical episodes, the different ways of neuronal haperexcitability and the different drug treatment programs. And are they comorbidity? If we can better understand the correlation between seizures and migraines, then this will help develop better guidelines for clinical diagnosis and treatment.

1 February 2017 in Clinical Neurophysiology
Verified
Journal Article
Closed access
LTLiwei Tang
Liwei Tang
ZXZheng Xiao
Zheng Xiao